Company: XXII
Filing Date: 2025-05-08
Form Type: S-3
Source: 0001641172-25-009301
Chunk: 13

Company: 22nd Century Group, Inc.
Filing Date: 2025-05-08
Form: S-3
Chunk 13
---
 as expressed in the Securities Act and is, therefore, unenforceable. In the event a claim for indemnification against such liabilities (other than payment by us for expenses incurred or paid by a director, officer or controlling person of ours in successful defense of any action, suit, or proceeding) is asserted by a director, officer or controlling person in connection with the securities being registered, we will, unless in the opinion of our legal counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question of whether such indemnification by our company is against public policy in the Securities Act and will be governed by the final adjudication of such issue.

Nasdaq Capital Market Listing

Our common stock is listed on the Nasdaq Capital Market under the symbol “XXII.”

Transfer Agent and Registrar

The transfer agent and registrar for our common stock is Continental Stock Transfer & Trust Company, One State Street, 30 thFloor, New York, NY 10004-1561.

| 6 |

<div align='center'>Selling StockholderS</div>

This prospectus relates to the resale from time to time by the selling stockholders named in this prospectus under the caption “Selling Stockholders,” or the Selling Stockholders, of 11,272,093 shares of our common stock, par value $0.00001 per share, or the Shares as follows: comprising up to (i) 6,889,497 shares of our common stock issued upon the exercise of previously outstanding warrants, (ii) 200,000 shares issued to settle outstanding debt and creditor obligations; (iii) 685,089 shares of our common stock issuable upon the exercise of outstanding warrants issued in a private placement on September 13, 2024, (iv) 628,916 shares of our common stock issuable upon the exercise of outstanding warrants issued in a private placement on October 1, 2024, (v) 34,887 shares of our common stock issuable upon the exercise of outstanding Placement Agent Warrants issued in a private placement on October 1, 2024; (vi) 815,363 shares of our common stock issuable upon the exercise of outstanding warrants issued in a private placement involving a warrant inducement, (vii) 34,384 shares of our common stock issuable upon the exercise of outstanding Placement Agent Warrants issued in a private placement involving a warrant inducement (viii) 1,887,379 shares of